Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial
Authors
Keywords
-
Journal
BLOOD
Volume 135, Issue 20, Pages 1739-1749
Publisher
American Society of Hematology
Online
2020-03-12
DOI
10.1182/blood.2020004823
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Role of Janus Kinase Signaling in Graft-Versus-Host Disease and Graft Versus Leukemia
- (2018) Mark A. Schroeder et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease
- (2018) John M. Magenau et al. BLOOD
- MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD
- (2018) Hannah Major-Monfried et al. BLOOD
- Safety and Effectiveness of Vedolizumab in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease: A Retrospective Record Review
- (2018) Yngvar Fløisand et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
- (2017) Francisco M. Marty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acute Graft-versus-Host Disease — Biologic Process, Prevention, and Therapy
- (2017) Robert Zeiser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients
- (2016) Nicola Polverelli et al. AMERICAN JOURNAL OF HEMATOLOGY
- International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium
- (2016) Andrew C. Harris et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Sibling Donors
- (2016) Aleksandr Lazaryan et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD
- (2016) Gérard Socié et al. BLOOD
- Patterns of infection and infection-related mortality in patients with steroid-refractory acute graft versus host disease
- (2016) I García-Cadenas et al. BONE MARROW TRANSPLANTATION
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
- (2015) Madan H. Jagasia et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
- (2015) R Zeiser et al. LEUKEMIA
- Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease
- (2014) S. Spoerl et al. BLOOD
- Extracorporeal Photopheresis versus Anticytokine Therapy as a Second-Line Treatment for Steroid-Refractory Acute GVHD: A Multicenter Comparative Analysis
- (2013) Madan Jagasia et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Response endpoints and failure-free survival after initial treatment for acute graft-versus-host disease
- (2013) Y. Inamoto et al. HAEMATOLOGICA
- First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation
- (2012) Paul J. Martin et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Steroid-Refractory Acute GVHD: Lack of Long-Term Improved Survival Using New Generation Anticytokine Treatment
- (2011) Aliénor Xhaard et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Risk factors for acute GVHD and survival after hematopoietic cell transplantation
- (2011) M. Jagasia et al. BLOOD
- Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
- (2010) Ted A. Gooley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Infliximab for Managing Steroid-Refractory Acute Graft-versus-Host Disease
- (2009) Joseph Pidala et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Endpoints for Clinical Trials Testing Treatment of Acute Graft-versus-Host Disease: A Joint Statement
- (2009) Paul J. Martin et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started